News & Insights

OriGen Biomedical named #37 by Fortune Magazine and the Initiative for a Competitive Inner City (ICIC) in the 2014 ICIC 100 and #3 in the Healthcare &...

The list, started in 1982, ranks the most successful private companies in the United States; this is OriGen’s 4th year on the Inc 500/5000.

The Aggie 100 is an annual award that recognizes the 100 fastest-growing companies in the world that are owned or led by Texas A&M University alum...

AUSTIN, June 2013: OriGen Biomedical, Inc. announced the acquisition of Alliance Pharmaceutical Corp.’s, San Diego, CA, LiquiVent® clinical trial data...

Inc. Magazine ranked OriGen #885 in its Annual 2012 Inc. 500/5000 list. This ranks the nation’s fastest-growing private companies. This is our s...

OriGen’s facility at 7000 Burleson Rd, Bldg D Austin, TX  78744 expands to 45,000 SF (4180 M2) – adding two additional clean rooms; one fo...

Our ranking was #52 in the 2011 Initiative for a Competitive Inner City (ICIC). Up from #90 ranking in 2010.

Bloomberg Businessweek magazine named OriGen Biomedical as the 90th fastest growing Inner City business in the US for the fiscal year ending in 2008. ...

OriGen is excited to announce that we have relocated to a new, custom-built 26,000 sq ft (2500 M2) production facility that will allow for further exp...